Chemed (NYSE:CHE - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 24.950-25.450 for the period, compared to the consensus estimate of 24.890. The company issued revenue guidance of -.
Chemed Price Performance
Shares of CHE traded up $14.34 during mid-day trading on Friday, reaching $600.46. The stock had a trading volume of 141,070 shares, compared to its average volume of 96,197. Chemed has a 52-week low of $512.12 and a 52-week high of $654.62. The business's fifty day moving average is $546.69 and its 200 day moving average is $563.39. The firm has a market cap of $9.04 billion, a price-to-earnings ratio of 30.34, a P/E/G ratio of 2.15 and a beta of 0.48.
Chemed Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date is Monday, February 24th. Chemed's dividend payout ratio (DPR) is presently 10.05%.
Analyst Ratings Changes
CHE has been the subject of several research analyst reports. StockNews.com lowered shares of Chemed from a "buy" rating to a "hold" rating in a research note on Thursday. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.
Read Our Latest Stock Analysis on CHE
Insider Transactions at Chemed
In other news, VP Brian C. Judkins bought 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 3.32% of the company's stock.
About Chemed
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
